ABEO vs ECL
Abeona Therapeutics Inc (ABEO) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ABEO currently screens at market cap $301.8M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ABEO and ECL stock pages for the full models.
Not investment advice.